I’ve been looking into retatrutide vs tirzepatide recently, particularly from an Australian research perspective, and the differences between the two are quite interesting.
Tirzepatide targets two receptors - GIP and GLP-1 - whereas retatrutide is being investigated as a triple receptor...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.